Figures & data
Table 1. Sociodemographic and clinical characteristics of patients with controlled and uncontrolled SA.
Figure 1. The mean (SD) utility (EQ-5D-5L and AQL-5D) in patients with controlled and uncontrolled SA. AQL-5D: Asthma Quality of Life Utility Index-5 Dimensions; EQ-5D: EuroQoL 5 dimensions; SA: severe asthma; SD: standard deviation.
![Figure 1. The mean (SD) utility (EQ-5D-5L and AQL-5D) in patients with controlled and uncontrolled SA. AQL-5D: Asthma Quality of Life Utility Index-5 Dimensions; EQ-5D: EuroQoL 5 dimensions; SA: severe asthma; SD: standard deviation.](/cms/asset/2d6594bf-4240-4ee1-989a-2504ae94a63e/ijas_a_2241891_f0001_c.jpg)
Figure 3. Percentage of patients with controlled and uncontrolled SA who reported affected dimensions of the EQ-5D-5L descriptive system.
![Figure 3. Percentage of patients with controlled and uncontrolled SA who reported affected dimensions of the EQ-5D-5L descriptive system.](/cms/asset/be6b2b3d-516b-4192-9943-420f8ea3c904/ijas_a_2241891_f0003_c.jpg)
Figure 4. Mean AQLQ-5D scores (total and in all domains) of patients with controlled and uncontrolled SA.
![Figure 4. Mean AQLQ-5D scores (total and in all domains) of patients with controlled and uncontrolled SA.](/cms/asset/b3ca1533-ceb4-4008-a10e-47e4c1ad81d5/ijas_a_2241891_f0004_c.jpg)
Table 2. Healthcare resource use of patients with controlled and uncontrolled SA in the previous 12 months.
Supplemental Material
Download MS Word (70.3 KB)Data availability statement
The datasets generated and/or analyzed during the current study are not publicly available due to all information related to the study is considered confidential until publication but are available from the corresponding author on reasonable request.